FOX04-DRI 5mg

Description

Advance your laboratory research with FOX04-DRI 5mg (5mg), a premium research-grade peptide supplied by Aura Peptide Co. Australia. FOX04-DRI 5mg is widely referenced in biochemical and cellular research for controlled experimental studies, valued for its purity, stability and reproducible performance in laboratory environments.

Manufactured in accredited laboratories using advanced peptide synthesis methods, every FOX04-DRI 5mg vial is independently batch-tested to verify identity, purity and consistency. Supplied as a lyophilised powder for professional research use only.

Key features

• • High-purity FOX04-DRI 5mg research peptide
• • 5mg lyophilised powder per vial
• • HPLC-MS verified purity (99.79%)
• • Manufactured in accredited laboratories
• • Sterile, tamper-evident vial suitable for laboratory handling
• • Fast, discreet Australia-wide shipping

Specifications

Product name

FOX04-DRI 5mg

Peptide grade

Research Grade

Quantity

5mg per vial

Form

Lyophilised powder

Purity

99.79% (HPLC-MS tested)

Appearance

White/off-white lyophilised powder

Storage

Cool, dry environment; refrigeration recommended

Packaging

Sterile, tamper-evident research vial

Reconstitution

Reconstitute with bacteriostatic water, adding solvent slowly against the vial wall. Do not shake — swirl gently until fully dissolved. Store reconstituted solution refrigerated at 2–8°C and protect from light. Bacteriostatic water is available separately in the catalogue.

Research Use Only — FOX04-DRI 5mg is supplied strictly for in-vitro laboratory and research purposes. Not for human or animal consumption, and not a medicine, supplement or therapeutic good.